The effectiveness of COVID-19 vaccines for people in American nursing homes and long-term care facilities, where residents are often elderly and frail, has dropped since the Delta variant became dominant in the United States, government researchers said on Wednesday.
Despite this decline, the vaccines are still highly effective at preventing illness severe enough to require hospitalization, according to research published in the U.S. Centers for Disease Control and Prevention's (CDC) Morbidity and Mortality Weekly Report.
The spread of the highly infectious Delta variant, which according to CDC data accounted last month for more than 80% of new U.S. infections, has complicated efforts to combat the pandemic in the United States and globally.
CDC researchers compared weekly data from 3,862 nursing homes and long-term care facilities spanning March 1 to May 9, before Delta became widespread, to data from 14,917 such facilities covering June 21 to Aug. 9, when the variant was responsible for the majority of new infections.
They found that efficacy of the two-dose vaccines from Pfizer/BioNTech and Moderna for preventing any coronavirus infection - mild or severe - dropped from 74.7% to 53.1%. Effectiveness estimates were similar for the Pfizer-BioNTech and Moderna vaccines, they said.
The study's findings https://bit.ly/3mebUYT were cited by federal health officials on Wednesday in their announcement that COVID-19 booster shots would be made widely available https://www.reuters.com/world/us/us-start-offering-covid-19-vaccine-booster-doses-september-2021-08-18 to Americans beginning on Sept. 20, with protection from initial vaccination waning over time.
The first groups to receive those boosters will include nursing home residents and other elderly Americans, as well as people with weak immune systems.
"Because the Delta variant became prominent in the United States within six months after the initial vaccine rollout to nursing home residents, we could not determine if the lower vaccine effectiveness seen in June-July in this study was due to potential waning immunity, reduced protection against the Delta variant, or a combination of both factors," CDC epidemiologist Dr. Srinivas Nanduri said.
In a second study https://bit.ly/3AS7Cub, New York State Department of Health officials found that by late July, 65% of New York adults had been fully vaccinated with two doses of the Pfizer/BioNTech or Moderna shots or one dose of the Johnson & Johnson shot.
Between early May and late July, the vaccines' effectiveness for preventing new infections dropped from 91.7% to 79.8%, the study found. Vaccine efficacy at preventing hospitalization held steady, ranging from 91.9% to 95.3%, it found.
The effectiveness of the two-dose vaccines against hospitalization lasts at least six months, according to a separate study https://bit.ly/2Wa8kEm by researchers in 18 U.S. states who reviewed data from 3,089 hospitalized patients, including 1,194 with COVID-19.
Vaccine efficacy against COVID-19-associated hospitalization was 86% between two and 12 weeks from receipt of the second vaccine dose, they found. It was 84% between 13 and 24 weeks, with no significant change between these periods, they found. Over the full six months, they found, it was 90% among adults without immunocompromising conditions.
Reuters
Thu Aug 19 2021
A syringe is filled with a dose of Pfizer's COVID-19 vaccine at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, U.S., February 23, 2021. REUTERS/Brendan McDermid
Israel pertahan hak serang Rafah di ICJ
Pasukan peguam Israel di ICJ menegaskan ia mempunyai hak mempertahankan diri dari Hamas, walaupun Afrika Selatan memohon hentikan serangan di Rafah.
Bantuan AS untuk Gaza tiba di Cyprus menanti pemindahan
White House mengesahkan bantuan tambahan AS untuk Gaza kini tiba di Cyprus, menunggu pemindahan melalui jeti sementara yang dibina di wilayah itu.
FIFA dapatkan nasihat perundangan sebelum gantung Israel
FIFA akan mendapatkan nasihat perundangan sebelum bersidang pada Julai untuk membincangkan permohonan Palestin menggantung Israel dari perlawanan antarabangsa.
Alami era baharu televisyen dikuasakan AI daripada Samsung
Empat ciri utama diketengahkan: 'AI Image Upscaling', 'AI Sound', 'AI Energy Mode', dan paling penting, 'AI Security.'
ProAIBI2024 anjuran Politeknik dan Kolej Komuniti fokus Kelestarian Alam Bina
ProAlBi 2024 tahun ini memperkenalkan segmen baru dengan kolaborasi antarabangsa dari Kolok Industrial and Community Education College, Thailand.
Malaysia, Uzbekistan akan ubah Jawatankuasa Bersama Dalam Perdagangan kepada Suruhanjaya Bersama
Kedua-dua negara juga bersetuju untuk menganjurkan penglibatan perniagaan dua hala secara kerap.
Polis siasat ancaman jemaah islamiyah dalam negara
Polis Diraja Malaysia (PDRM) sedang menyiasat sejauh mana ancaman daripada Jemaah Islamiyah (JI) di dalam negara ketika ini, susulan kejadian serangan di Balai Polis Ulu Tiram, Johor pada awal pagi Jumaat.
Komuniti perniagaan perlu teroka peluang di Kazakhstan - PM
Beliau berkata kerajaan sentiasa memberikan kemudahan dan sokongan kepada komuniti perniagaan untuk mengembangkan operasi mereka ke luar negara.
Kerajaan teruskan sistem e-Jamin selari aspirasi pendigitalan
Kerajaan akan meneruskan penggunaan sistem E-Jamin bagi memudahkan urusan ikat jamin, selari dengan aspirasi Kerajaan Madani dan hasrat PM Anwar Ibrahim.
Malaysia-Uzbekistan teroka kerjasama dalam sektor petrokimia
Malaysia dan Uzbekistan bersetuju untuk meneroka peluang kerjasama dalam sektor petrokimia dan penyelesaian tenaga hijau bersih.
Perdana Menteri Malaysia Datuk Seri Anwar Ibrahim dan Presiden Uzbekistan Shavkat Mirziyoyev menerusi satu kenyataan bersama berkata Uzbekistan berminat untuk menjalin kerjasama dengan syarikat minyak nasional Malaysia, Petronas.
Perdana Menteri Malaysia Datuk Seri Anwar Ibrahim dan Presiden Uzbekistan Shavkat Mirziyoyev menerusi satu kenyataan bersama berkata Uzbekistan berminat untuk menjalin kerjasama dengan syarikat minyak nasional Malaysia, Petronas.
Persiapan Sarawak untuk RMK13 akan bermula tahun ini - Abang Johari
Persiapan Sarawak untuk RMK13 akan dimulakan tahun ini dengan tumpuan utama untuk melaksanakan fasa kedua PCDS 2030.
Kerajaan jamin sediakan rawatan kesan sampingan vaksin COVID-19 termasuk AstraZeneca - Dzulkefly
Kerajaan memberi jaminan akan menyediakan rawatan susulan bagi penerima vaksin COVID-19 termasuk AstraZeneca yang terbukti mengalami kesan sampingan.
KKM keluar kenyataan berkaitan vaksin AstraZeneca dalam masa terdekat
KKM akan mengeluarkan kenyataan berhubung isu penarikan balik vaksin COVID-19 keluaran AstraZeneca dalam masa terdekat.
Isu tunggakan cetakan MyKid bakal selesai Julai ini - JPN
Isu cetakan MyKid yang tertunggak akibat masalah perolehan bekalan mikrocip semasa pandemik COVID-19 lalu dijangka dapat diselesaikan pada Julai ini secara berperingkat di seluruh negara.
Program Jana Wibawa dilaksana selepas dapat persetujuan Jemaah Menteri - Saksi
Mahkamah Sesyen di sini hari ini diberitahu bahawa cadangan mengenai Jana Wibawa telah dibawa ke mesyuarat untuk pertimbangan sebelum Jemaah Menteri memutuskan supaya program itu diteruskan pada 2020.
Kelaparan akut jejaskan 281.6 juta orang tahun lepas - PBB
Tahap bahaya kelaparan akut menjejaskan 281.6 juta orang tahun lepas, tahun kelima berturut-turut bahawa ketakjaminan makanan semakin memburuk.
Hamilton optimis kedudukan lebih baik di GP China
Lewis Hamilton melihat potensi kedudukan yang lebih baik dalam saingan Grand Prix yang kembali ke China buat pertama kali dalam tempoh lima tahun, hujung minggu ini.
'Selfish!' - Fasha Sandha sedih raya di Perlis tak jadi gara-gara dijangkiti COVID-19
Fasha berkata dia mula melakukan pemeriksaan COVID-19 selepas berasa tidak sihat badan dan mengalami bersin tidak henti sejak Raya pertama.
Kes COVID-19 catat penurunan ketara pada ME 14/2024 - KKM
Jumlah kes COVID-19 menurun 97.1 peratus kepada 493 kes pada Minggu Epidemiologi ke-14 (ME 14/2024) iaitu bagi tempoh 31 Mac hingga 6 April lepas berbanding 17,256 kes pada ME 1/2024.
China jadikan pengalaman pencegahan COVID-19 untuk hadapi pandemik masa depan
China akan menjadikan pengalaman dalam pencegahan dan kawalan COVID-19 untuk membuat persediaan yang lebih proaktif untuk menghadapi pandemik masa depan seperti "Penyakit X".